In the News |
June 25, 2026
Human-Based Preclinical Models May Improve Toxicity Prediction in Oncology Development

At BIO International Convention 2026, Mohit Trikha, PhD, CEO of Kiva Bioscience, discussed why emerging human-based preclinical models may have their greatest impact in predicting drug toxicity and tolerability rather than replacing animal testing outright.